Economic Evaluation
Policy Options for Formulary Development in Middle-income Countries
1 January 2017
PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. This report presents a framework…
Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study
1 January 2017
PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. In a previous…
Improving Efficiency and Resource Allocation in Future Cancer Care
9 January 2016
The economic burden that cancer poses on our society is staggering – 25 million years of healthy life lost, at cost of €126 billion including €52…
Four Case Studies to Explore the Added Value of Oxford AHSN
9 January 2016
The Oxford Academic Health Science Network (Oxford AHSN) wishes to demonstrate the value of the various projects and programmes that the network has developed and implemented since it was established in 2013.
Model of Behaviour within Fuzzy Budget Constraints
1 December 2015
This paper presents a model to capture the behaviour of health sector decision makers when making resource allocation decisions on the level and mix of healthcare…
Improving the Fiscal and Political Sustainability of Health Systems through Integrated Population Needs-Based Planning
6 January 2015
It is often argued that the demands for increased healthcare expenditure arising from an ageing population, advancing technologies, and increasing expectations, warrant higher healthcare budgets. Professor…
Contracting for Quality in the NHS
1 January 2014
This monograph, based on Professor Maynard’s remarks at the 20th OHE Annual Lecture, explores the critical issue of ensuring the quality of care in the NHS.…
Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
12 January 2013
This paper counters the recently-published recommendation by Claxton et al[1] that NICE should lower its cost-per-QALY threshold from the current £20,000–£30,000 official range to £12,936. The…
Searching for Cost-effectiveness Thresholds in NHS Scotland
1 December 2013
This research examines the use of QALY thresholds in NHS Scotland in 2012-13 for health services that were “at the margin”, i.e. those for which investment or…